Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-κB in human dermal fibroblasts

Acta Pharmacologica Sinica

Volumn 32, Issue 5, 2011, Pages 637-646

  Han, Dong Wook ^a   Lee, Mi Hee ^b   Kim, Hak Hee ^b,c   Hyon, Suong Hyu ^c   Park, Jong Chul ^b  

^a Pusan National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

( )epigallocatechin 3 gallate (EGCG); cell cycle; fibroblasts; green tea; nuclear factor B (NF B); polyphenol

Indexed keywords

COMPLEMENTARY DNA; CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE 1; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; ASSAY; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CYTOPLASM; DERMIS; DNA MICROARRAY; DOSE RESPONSE; DRUG LABELING; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; HUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TEA;

ANTIOXIDANTS; APOPTOSIS; CAMELLIA SINENSIS; CATECHIN; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INFANT, NEWBORN; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; SKIN;

EID: 79959740010     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.17     Document Type: Article

References (33)

1. Na HK, Surh YJ. Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate. Mol Nutr Food Res 2006; 50: 152-9.
2. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 2006; 66: 2500-5.
3. Kwon KH, Barve A, Yu S, Huang MT, Kong AN. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharmacol Sin 2007; 28: 1409-21. (Pubitemid 47366691)
4. Nair S, Barve A, Khor TO, Shen GX, Lin W, Chan JY, et al. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3- gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells. Acta Pharmacol Sin 2010; 31: 1223-40.
5. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997; 89: 1881-6. (Pubitemid 28009824)
6. Ahmad N, Gupta S, Mukhtar H. Green tea polyphenol epigallocatechin- 3-gallate differentially modulates nuclear factor-κB in cancer cells versus normal cells. Arch Biochem Biophys 2000; 376: 338-46. (Pubitemid 30210882)
7. Chen ZP, Schell JB, Ho CT, Chen KY. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett 1998; 129: 173-9. (Pubitemid 28386599)
8. Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn J Cancer Res 1997; 88: 639-43. (Pubitemid 27394047)
9. 3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration. J Agric Food Chem 2001; 49: 1042-8.
10. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998; 19: 1771-6.
11. 3H]- epigallocatechin gallate in beagle dogs. Int J Toxicol 2003; 22: 187-93.
12. Ahmad N, Gupta S, Husain MM, Heiskanen KM, Mukhtar H. Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res 2000; 6: 1524-8. (Pubitemid 30226242)
13. Donnerstag B, Ohlenschlager G, Cinatl J, Amrani M, Hofmann D, Flindt S, et al. Reduced glutathione and S-acetylglutathione as selective apoptosis-inducing agents in cancer therapy. Cancer Lett 1996; 110: 63-70. (Pubitemid 27042922)
14. Khan N, Adhami VM, Mukhtar H. Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol 2008; 76: 1333-9.
15. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 2008; 52: 507-26.
16. Bae JY, Kanamune J, Han DW, Matsumura K, Hyon SH. Reversible regulation of cell cycle-related genes by epigallocatechin gallate for hibernation of neonatal human tarsal fibroblasts. Cell Transplant 2009; 18: 459-69.
17. Hyon SH, Kim DH. Hibernation of mammalian cells at a living body temperature. Biotechnol Bioprocess Eng 2001; 6: 289-92.
18. Matsumura K, Kim JY, Tsutsumi S, Hyon SH. Hibernation, reversible cell growth inhibition by epigallocatechin-3-O-gallate. J Biotechnol 2007; 127: 758-64. (Pubitemid 44959116)
19. Park JC, Park BJ, Suh H, Park BY, Rah DK. Comparative study on motility of the cultured fetal and neonatal dermal fibroblasts in extracellular matrix. Yonsei Med J 2001; 42: 587-94. (Pubitemid 34041128)
20. Han D-W, Matsumura K, Kim B, Hyon SH. Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells. Bioorg Med Chem 2008; 16: 9652-9.
21. Lee MH, Han DW, Hyon SH, Park JC. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB. Apoptosis 2011; 16: 75-85.
22. Nair S, Li W, Kong AN. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells. Acta Pharmacol Sin 2007; 28: 459-72. (Pubitemid 46496089)
23. Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, et al. Pharmacokinetics and safety of green tea polyphenols after multipledose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003; 9: 3312-9. (Pubitemid 37082725)
24. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 1997; 275: 523-7. (Pubitemid 27051906)
25. Piva R, Belardo G, Santoro MG. NF-κB: a stress-regulated switch for cell survival. Antioxid Redox Signal 2006; 8: 478-86. (Pubitemid 43741316)
26. Hong J, Lu H, Meng X, Ryu JH, Hara Y, Yang CS. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin- 3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res 2002; 62: 7241-6. (Pubitemid 36025245)
27. Palermo CM, Westlake CA, Gasiewicz TA. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry 2005; 44: 5041-52. (Pubitemid 40471220)
28. Uekusa Y, Kamihira M, Nakayama T. Dynamic behavior of tea catechins interacting with lipid membranes as determined by NMR spectroscopy. J Agric Food Chem 2007; 55: 9986-92. (Pubitemid 350305186)
29. Yang D, Liu J, Tian C, Zeng Y, Zheng YH, Fang Q, et al. Epigallocatechin gallate inhibits angiotensin II-induced endothelial barrier dysfunction via inhibition of the p38 MAPK/HSP27 pathway. Acta Pharmacol Sin 2010; 31: 1401-6.
30. Tachibana H, Koga K, Fujimura Y, Yamada K. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 2004; 11: 380-1. (Pubitemid 38436804)
31. Umeda D, Yano S, Yamada K, Tachibana H. Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J Biol Chem 2008; 283: 3050-8.
32. Kuzuhara T, Sei Y, Yamaguchi K, Suganuma M, Fujiki H. DNA and RNA as new binding targets of green tea catechins. J Biol Chem 2008; 281: 17446-56.
33. Kuzuhara T, Tanabe A, Sei Y, Yamaguchi K, Suganuma M, Fujiki H. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins. Mol Carcinog 2007; 46: 640-5 (Pubitemid 47255181)